ViewRay Inc VRAYQ:Over The Counter Mkt

*Data is delayed | Exchange | USD
Last | 05/20/24 EDT
0.00UNCH (UNCH)
52 week range
0.00 - 0.68
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.00
  • 52 Week High0.68
  • 52 Week High Date06/05/23
  • 52 Week Low0.00
  • 52 Week Low Date05/20/24

Key Stats

  • Market Cap183.402
  • Shares Out183.40M
  • 10 Day Average Volume9.92M
  • Dividend-
  • Dividend Yield-
  • Beta0.57
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.00
  • 52 Week High0.68
  • 52 Week High Date06/05/23
  • 52 Week Low0.00
  • 52 Week Low Date05/20/24
  • Market Cap183.402
  • Shares Out183.40M
  • 10 Day Average Volume9.92M
  • Dividend-
  • Dividend Yield-
  • Beta0.57
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.61
  • P/E (TTM)-0.00
  • Fwd P/E (NTM)-0.00
  • EBITDA (TTM)-102.79M
  • ROE (TTM)-108.91%
  • Revenue (TTM)105.864M
  • Gross Margin (TTM)8.05%
  • Net Margin (TTM)-104.30%
  • Debt To Equity (MRQ)140.73%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On ViewRay Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
ViewRay, Inc. is engaged in designing, manufacturing, and marketing the MRIdian MRI-Guided Radiation Therapy System. The MRIdian MR-Guided Radiation Therapy System integrates diagnostic MR imaging with radiation therapy delivery to enable on-table adaptive treatments with real-time tissue tracking and automatic beam gating. The MRIdian is comprised of three components, namely magnetic resonance imaging (MRI) system, radiation delivery system, and integrated treatment planning...
Daniel Moore
Independent Chairman of the Board
Paul Ziegler
President, Chief Executive Officer
Cassie Mahar
Interim Chief Financial Officer
Address
2 Thermo Fisher Way
Oakwood Village, OH
44146-6536
United States

Top Peers

SYMBOLLASTCHG%CHG
XTNT
Xtant Medical Holdings Inc
0.76+0.0065+0.8626%
FONR
Fonar Corp
14.50+0.09+0.62%
VERO
Venus Concept Inc
0.653+0.033+5.3226%
AKYA
Akoya Biosciences Inc
2.53-0.11-4.20%
STIM
Neuronetics Inc
2.39-0.05-2.05%